OR WAIT null SECS
Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.
January 15, 2010
A class of action has been filed that seeks to prevent Novartis' proposed merger with eye-care company Alcon, which will see Alcon's minority public shareholders "squeezed out at an unfair price", according to a statement from US law firm Labaton Sucharow LLP.
Many life sciences companies are likely to execute an acquisition in the next 12–24 months as economic conditions improve, according to Why capital matters, a global survey of senior executives in the life sciences sector conducted by Ernst & Young in 2009.
The EC has asked certain pharmaceutical companies to submit copies of their patent settlement agreements; in particular, the EC will be looking at settlements where an originator paid off a generic competitor in return for delayed market entry of a generic drug.
January 14, 2010
Many life-sciences companies are likely to execute an acquisition in the next 12-24 months, according to a survey by Ernst & Young.
The European Commission has asked certain pharmaceutical companies to submit copies of their patent-settlement agreements.
January 08, 2010
Microelectronics offers "striking opportunities" for advancing biomedical research and creating new markets for the medical sciences industry, according to analysis from Frost & Sullivan.